VMP 42210411000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Flecainide 50mg tablets
BNF code 0203020I0AAAKAK
Virtual Therapeutic Moiety Flecainide
Date identifier became valid 1 Sep 2023
Previous product identifier 318276009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Flecainide acetate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Flecainide 50mg tablets (AAH Hillcross)
Flecainide 50mg tablets (A A H Pharmaceuticals Ltd)
Flecainide 50mg tablets (Accord-UK Ltd)
Flecainide 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Flecainide 50mg tablets (Almus Pharmaceuticals Ltd)
Flecainide 50mg tablets (Brown & Burk UK Ltd)
Flecainide 50mg tablets (Medihealth (Northern) Ltd)
Flecainide 50mg tablets (Milpharm Ltd)
Flecainide 50mg tablets (Phoenix Healthcare Distribution Ltd)
Flecainide 50mg tablets (Sigma Pharmaceuticals Plc)
Flecainide 50mg tablets (Tillomed Laboratories Ltd)
Flecainide 50mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Flecainide 50mg tablets 100 tablet
Flecainide 50mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20240923000001, imported on 23rd September 2024 at 04:57:49.

Feedback